Molecular Partners AG

Schlieren, Zurich, Switzerland molecularpartners.com

Overview

Molecular Partners develops DARPin therapeutics, including radio-DARPin therapies and immune cell engagers, aimed at treating cancer patients.

Therapeutic areas

Oncology

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Molecular Partners AG in our records. PharmaTek screens the full directory against live FDA enforcement data.

Verified Supplier Partner

Is this Molecular Partners AG? Get in front of buyers actively sourcing.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Related companies

Bachem Holding AG
Switzerland
Novartis Oncology
Switzerland
3D Imaging Drug Design and Development LLC
United States
A. Menarini Manufacturing
Italy
A&B Pharmaceuticals
United States
Abgenix, Inc.
United States
Ablynx, a Sanofi company
Belgium
Accutest Research Laboratories (I) Pvt. Ltd.
India

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.

Start free trialBook a demo